Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Beach

Showing results (221-230 of 653) with videos related to

Pageof 66
Sort By:
Acta Neuropathologica Communications|December 23, 2019
Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathologyAnarmaa Mendsaikhan, Ikuo Tooyama, Jean-Pierre Bellier, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 19, 2018
Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementiaRaymond Q Migrino, Seth Truran, Nina Karamanova, et al.
Experimental Neurology|August 25, 2001
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanismL F Lue, D G Walker, L Brachova, et al.
Brain : a Journal of Neurology|August 19, 2007
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosisA Lockhart, J R Lamb, T Osredkar, et al.
Neurology|April 11, 2014
Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer diseasePengcheng Han, Winnie Liang, Leslie C Baxter, et al.
Environmental Science & Technology|January 28, 2026
Improved Sample Preparation for β-<i>N</i>-Methylamino-l-Alanine (BMAA) Analysis by Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry and Assessment of Freshwater Cyanobacterial Cultures from Aotearoa New ZealandCraig Waugh, Roel van Ginkel, Daniel G Beach, et al.
Frontiers in Molecular Neuroscience|December 6, 2021
Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson's Disease PatientsKatarína Tiklová, Linda Gillberg, Nikolaos Volakakis, et al.
Journal of Neurochemistry|January 29, 2008
In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brainLiang Ye, Ana Velasco, Graham Fraser, et al.
International Journal of Molecular Sciences|January 24, 2020
Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease BrainsDouglas G Walker, Tiffany M Tang, Anarmaa Mendsaikhan, et al.
Scientific Reports|May 6, 2017
Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutationMasato Hosokawa, Hiromi Kondo, Geidy E Serrano, et al.
Pageof 66

Showing results (221-230 of 653) with videos related to

Sort By:
Pageof 66
Acta Neuropathologica Communications|December 23, 2019
Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathologyAnarmaa Mendsaikhan, Ikuo Tooyama, Jean-Pierre Bellier, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 19, 2018
Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementiaRaymond Q Migrino, Seth Truran, Nina Karamanova, et al.
Experimental Neurology|August 25, 2001
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanismL F Lue, D G Walker, L Brachova, et al.
Brain : a Journal of Neurology|August 19, 2007
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosisA Lockhart, J R Lamb, T Osredkar, et al.
Neurology|April 11, 2014
Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer diseasePengcheng Han, Winnie Liang, Leslie C Baxter, et al.
Environmental Science & Technology|January 28, 2026
Improved Sample Preparation for β-<i>N</i>-Methylamino-l-Alanine (BMAA) Analysis by Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry and Assessment of Freshwater Cyanobacterial Cultures from Aotearoa New ZealandCraig Waugh, Roel van Ginkel, Daniel G Beach, et al.
Frontiers in Molecular Neuroscience|December 6, 2021
Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson's Disease PatientsKatarína Tiklová, Linda Gillberg, Nikolaos Volakakis, et al.
Journal of Neurochemistry|January 29, 2008
In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brainLiang Ye, Ana Velasco, Graham Fraser, et al.
International Journal of Molecular Sciences|January 24, 2020
Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease BrainsDouglas G Walker, Tiffany M Tang, Anarmaa Mendsaikhan, et al.
Scientific Reports|May 6, 2017
Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutationMasato Hosokawa, Hiromi Kondo, Geidy E Serrano, et al.
Pageof 66